Sethuraman Natarajan

Number of records: 22
SEC FilingCompany/StockTrade DateTransactionSharesAvg. PriceTotal% HoldingsGain/Loss
10-Sep-24 4:32 PM
View: 
Entrada Therapeutics, Inc. (TRDA) 09-Sep-24Sale (Planned) 2,642$15.09$39,862.20(1%)
186.46K to 183.82K
10-Sep-24 4:32 PM
View: 
Entrada Therapeutics, Inc. (TRDA) 06-Sep-24Private Sale (Planned) 600$15.24$9,141.36(< 1%)
187.06K to 186.46K
05-Sep-24 6:47 PM
View: 
Entrada Therapeutics, Inc. (TRDA) 05-Sep-24Payment of Exercise 167$15.13$2,526.04(< 1%)
187.22K to 187.06K
05-Sep-24 6:47 PM
View: 
Entrada Therapeutics, Inc. (TRDA) 04-Sep-24Payment of Exercise 955$15.42$14,729.30(< 1%)
188.18K to 187.22K
05-Sep-24 6:47 PM
View: 
Entrada Therapeutics, Inc. (TRDA) 03-Sep-24Payment of Exercise 634$16.08$10,195.50(< 1%)
188.81K to 188.18K
16-Jul-24 4:43 PM
View: 
Entrada Therapeutics, Inc. (TRDA) 15-Jul-24Sale (Planned) 638$18.00$11,484.00(< 1%)
189.45K to 188.81K
16-Jul-24 4:43 PM
View: 
Entrada Therapeutics, Inc. (TRDA) 12-Jul-24Private Sale (Planned) 600$18.00$10,800.00(< 1%)
190.05K to 189.45K
20-May-24 5:26 PM
View: 
Entrada Therapeutics, Inc. (TRDA) 20-May-24Sale (Planned) 9,675$15.19$146,944.00(5%)
199.73K to 190.05K
20-May-24 5:26 PM
View: 
Entrada Therapeutics, Inc. (TRDA) 17-May-24Sale (Planned) 8,305$15.14$125,751.00(4%)
208.03K to 199.73K
20-May-24 5:26 PM
View: 
Entrada Therapeutics, Inc. (TRDA) 16-May-24Private Sale (Planned) 1,000$15.00$15,000.00(< 1%)
209.03K to 208.03K
05-Mar-24 7:44 PM
View: 
Entrada Therapeutics, Inc. (TRDA) 05-Mar-24Payment of Exercise 1,505$12.28$18,479.60(< 1%)
210.54K to 209.03K
05-Mar-24 7:44 PM
View: 
Entrada Therapeutics, Inc. (TRDA) 04-Mar-24Payment of Exercise 761$12.94$9,844.84(< 1%)
211.3K to 210.54K
05-Mar-24 7:44 PM
View: 
Entrada Therapeutics, Inc. (TRDA) 01-Mar-24Grant 44,100----26%
167.2K to 211.3K
06-Sep-23 5:09 PM
View: 
Entrada Therapeutics, Inc. (TRDA) 05-Sep-23Payment of Exercise 449$14.46$6,493.66(< 1%)
167.65K to 167.2K
06-Sep-23 5:09 PM
View: 
Entrada Therapeutics, Inc. (TRDA) 01-Sep-23Grant 14,200----9%
153.45K to 167.65K
12-Jul-23 4:32 PM
View: 
Entrada Therapeutics, Inc. (TRDA) 11-Jul-23Sale (Planned) 14,852$18.04$267,915.00(9%)
168.3K to 153.45K
12-Jul-23 4:32 PM
View: 
Entrada Therapeutics, Inc. (TRDA) 10-Jul-23Private Sale (Planned) 3,026$18.00$54,474.10(2%)
171.32K to 168.3K
19-Apr-23 6:06 PM
View: 
Entrada Therapeutics, Inc. (TRDA) 17-Apr-23Private Sale (Planned) 3,961$18.00$71,315.80(2%)
175.29K to 171.32K
03-Mar-23 4:36 PM
View: 
Entrada Therapeutics, Inc. (TRDA) 02-Mar-23Payment of Exercise 1,058$11.60$12,268.80(< 1%)
190.54K to 189.49K
03-Mar-23 4:36 PM
View: 
Entrada Therapeutics, Inc. (TRDA) 01-Mar-23Grant 28,400----18%
162.14K to 190.54K
06-Sep-22 4:33 PM
View: 
Entrada Therapeutics, Inc. (TRDA) 01-Sep-22Grant 5,794----4%
156.35K to 162.14K
03-Mar-22 4:10 PM
View: 
Entrada Therapeutics, Inc. (TRDA) 01-Mar-22Grant 11,588----8%
144.76K to 156.35K